Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: vandetanibFind trials that include: Any drugs shown Results 1-5 of 5 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Vandetanib and Metformin Hydrochloride in Treating Patients with Advanced Kidney Cancer Status: ActivePhase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 15-C-0157, NCI-2015-01978, P152144, NCT02495103 2. Cisplatin or Carboplatin and Etoposide With or Without Vandetanib in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer or High-Grade or Poorly Undifferentiated Neuroendocrine Cancer Status: ActivePhase: Phase IIType: TreatmentAge: 18 and overTrial IDs: LUN06-113, NCI-2013-00309, 0712-21, 1011004344, IRUSZACT0083, NCT00613626 3. Vandetanib in Preventing Head and Neck Cancer in Patients with Precancerous Head and Neck Lesions Status: ActivePhase: Phase IIType: Biomarker/Laboratory analysis, PreventionAge: 18 and overTrial IDs: 11-0265, NCI-2011-01246, NCT01414426 4. Vandetanib in Treating Patients with Breast Cancer Status: ActivePhase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: 18 and olderTrial IDs: 201301763, NCI-2013-01699, 02130107, NCT01934335 5. Vandetanib and Everolimus in Treating Patients with Advanced or Metastatic Cancer Status: ActivePhase: Phase IType: TreatmentAge: Not specifiedTrial IDs: 2011-0953, NCI-2012-00782, 0953, NCT01582191 Select All on Page Start Over
